DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

References

Henderson EJ, Lord SR, Brodie MA. et al.
Rivastigmine for gait stability in patients with Parkinsonʼs disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet Neurol 2016;
15: 249-258

Download Bibliographical Data

Search in:
Access:
Access: